JPY 953.0
(1.6%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 149.66 Billion JPY | -11.51% |
2022 | 148.61 Billion JPY | -5.16% |
2021 | 156.7 Billion JPY | 24.65% |
2020 | 125.71 Billion JPY | 1.1% |
2019 | 124.35 Billion JPY | 31.46% |
2018 | 94.59 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 36.2 Billion JPY | -3.59% |
2023 Q4 | 37.54 Billion JPY | -24.99% |
2023 FY | 131.5 Billion JPY | -11.51% |
2023 Q3 | 50.05 Billion JPY | 42.33% |
2023 Q2 | 35.17 Billion JPY | -1.2% |
2023 Q1 | 35.59 Billion JPY | -18.01% |
2022 Q3 | 35 Billion JPY | 2.26% |
2022 Q1 | 35.96 Billion JPY | -35.92% |
2022 Q4 | 43.41 Billion JPY | 24.03% |
2022 FY | 148.61 Billion JPY | -5.16% |
2022 Q2 | 34.23 Billion JPY | -4.82% |
2021 FY | 156.7 Billion JPY | 24.65% |
2021 Q1 | 34.13 Billion JPY | -10.4% |
2021 Q3 | 32.04 Billion JPY | -6.83% |
2021 Q2 | 34.39 Billion JPY | 0.75% |
2021 Q4 | 56.12 Billion JPY | 75.15% |
2020 FY | 125.71 Billion JPY | 1.1% |
2020 Q2 | 26.69 Billion JPY | -13.37% |
2020 Q1 | 30.81 Billion JPY | 0.0% |
2020 Q3 | 30.09 Billion JPY | 12.73% |
2020 Q4 | 38.1 Billion JPY | 26.6% |
2019 FY | 124.35 Billion JPY | 31.46% |
2018 FY | 94.59 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
DVx Inc. | 3.96 Billion JPY | -3675.725% |
Seikagaku Corporation | 16.44 Billion JPY | -810.137% |
Eiken Chemical Co., Ltd. | 13.34 Billion JPY | -1021.323% |
Create Medic Co., Ltd. | 4.67 Billion JPY | -3101.282% |
Techno Medica Co., Ltd. | 3.26 Billion JPY | -4486.955% |
Rion Co., Ltd. | 10.85 Billion JPY | -1278.475% |
Nihon Kohden Corporation | 91.75 Billion JPY | -63.11% |
Fukuda Denshi Co., Ltd. | 47.94 Billion JPY | -212.175% |
Japan Lifeline Co., Ltd. | 19.34 Billion JPY | -673.852% |
Japan Medical Dynamic Marketing, INC. | 11.65 Billion JPY | -1184.099% |
3-D Matrix, Ltd. | 5.2 Billion JPY | -2776.232% |
CYBERDYNE Inc. | 4.12 Billion JPY | -3524.679% |